May toxicity of amiodarone be prevented by antioxidants? A cell-culture study

Journal of Cardiothoracic Surgery

Volumn 7, Issue 1, 2012, Pages

  Durukan, Ahmet B ^a   Erdem, Beril ^b   Durukan, Elif ^c   Sevim, Handan ^b   Karaduman, Tugce ^b   Gurbuz, Hasan A ^a   Gurpinar, Aylin ^b   Yorgancioglu, Cem ^a  

^a Medicana International Ankara Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

Amiodarone; Cell culture; Cytotoxicity; N acetyl cysteine; Vitamin C

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; ANTIOXIDANT; ASCORBIC ACID;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; FIBROBLAST; MOUSE; OXIDATIVE STRESS;

ACETYLCYSTEINE; AMIODARONE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CELL LINE, TRANSFORMED; CELL SURVIVAL; DRUG INTERACTIONS; FIBROBLASTS; MICE; OXIDATIVE STRESS;

EID: 84862753064     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-7-61     Document Type: Article

References (26)

1. Zebis LR, Christensen T, Kristiansen IS, Hjortdal VE. Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. Ann Thorac Surg 2008, 85:28-33. 10.1016/j.athoracsur.2007.07.060, 18154772.
2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Heuzey JL, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. Circulation 2006, 114:700-752.
3. Jackevicius CA, Tom A, Essebag V, Eisenberg MJ, Rahme E, Tu JV, Humphries K, Behlouli H, Pilote L. Population-level i{dotless}ncidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol 2011, 108:705-710. 10.1016/j.amjcard.2011.04.024, 21704281.
4. Rizzioli E, Incasa E, Gamberini S, Savelli S, Zangirolami A, Tampieri M, Manfredin R. Acute toxic hepatitis after amiodarone intravenous loading. Am J Emerg Med 2007, 25:1082. e1-1082.e4.
5. Cohen BI, Pagnillo BS, Musikant BL, Deutsch AS. An in vitro study of the cytotoxicity of two root canal sealers. J Endod 2000, 26:228-229. 10.1097/00004770-200004000-00008, 11199724.
6. Beriat GK, Akmansu SH, Gurpinar OA, Onur MA, Alhan A. The cytotoxic effect of nasodren nasal spray (Cyclamen Europaeum Extract) in L929 fibroblastic cell culture. Turkiye Klinikleri J Med Sci 2011, 31:287-296.
7. Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdourian G, Alpert JS. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 1983, 67:1347-1355. 10.1161/01.CIR.67.6.1347, 6851030.
8. Candinas R, Frielingsdorf J, Carrel T, Turina M, Follath F. Myocardial amiodarone concentrations after short and long-term treatment in patients with end-stage heart failure. Eur J Clin Pharmacol 1998, 53:331-336. 10.1007/s002280050388, 9516032.
9. Golli-Bennour EE, Bouslimi A, Zouaoui O, Achour A, Bacha H. Cytotoxicity effects of amiodarone on cultured cells. Exp Toxicol Pathol 2010,
10. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987, 47:936-942.
11. Echadidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008, 51:793-801. 10.1016/j.jacc.2007.10.043, 18294562.
12. Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dugenis D. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg 2010, 5:121. 10.1186/1749-8090-5-121, 3006380, 21118555.
13. Workman AJ, Smith GL, Rankin AC. Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Therap 2011, 131:221-241.
14. Woklove N, Baltzan M. Amiodarone pulmonary toxicity. Can Resp J 2009, 16:43-48.
15. Bolt MW, Racz WJ, Brien JF, Massey TE. Effects of vitamin E on cytotoxicity of amiodarone and N-desethylamiodarone in isolated hamster lung cells. Toxicology 2001, 166:109-118. 10.1016/S0300-483X(01)00451-6, 11543907.
16. Card JW, Racz WJ, Brien JF, Massey TE. Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with supression of transforming growth factor-beta 1 gene expression, but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther 2003, 304:277-283. 10.1124/jpet.102.043208, 12490602.
17. Agoston M, Örsi F, Feher E, Hagyma K, Orosz Z, Blazovics A, Feher J, Vereckei A. Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats. Toxicology 2003, 190:231-241. 10.1016/S0300-483X(03)00188-4, 12927377.
18. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999, 69:1086-1107.
19. Viswanatha-Swamy AH, Wangikar U, Koti BC, Thippeswamy AH, Ronad PM, Manjula DV. Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats. Indian J Pharmacol 2011, 43(5):507-511. 10.4103/0253-7613.84952, 3195117, 22021990.
20. Lee HC, Sheu SH, Liu IH, Lee CC, Hsieh CC, Yen HW, Lai WT, Chang JG. Impact of short-duration administration of N-acetylcysteine, probucol and ascorbic acid on contrast-induced cytotoxicity. J Nephrol 2012, 25:56-62. 10.5301/JN.2011.7741, 21534235.
21. Sansone RA, Sansone LA. Getting a Knack for NAC: N-Acetyl-Cysteine. Innov Clin Neurosci 2011, 8:10-14. 3257984, 22247812.
22. Rodrigo R, Vinay J, Castillo R, Cereceda M, Asenjo R, Zamorano J, Araya J, Castillo-Koch R, Espinoza J, Larrain E. Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol 2010, 138:221-228. 10.1016/j.ijcard.2009.04.043, 19446899.
23. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001, 89:E32-E38. 10.1161/hh1801.097644, 11557745.
24. Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, Siogas K, Goudevenos JA. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 2005, 102:321-326. 10.1016/j.ijcard.2004.12.041, 15982504.
25. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, İbrisim E. N-actylcysteine for the prevention of postoperative atrial fibrillation: a prospective randomized, placebo-controlled pilot study. Eur Heart J 2008, 29:625-631. 10.1093/eurheartj/ehn011, 18263874.
26. Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Capitanio N, Tamborra R, Romano AD, Quinto M, Blonda M, Vendemiale G, Altomare E. Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. Free Radic Biol Med 2011, 51:2234-2242. 10.1016/j.freeradbiomed.2011.09.004, 21971348.